Status and phase
Conditions
Treatments
About
The main purpose of this study is to evaluate the safety and tolerability of IBI3020 and to determine the maximum tolerated dose (MTD) and/or the recommended dose for expansion (RP2D) of IBI3020.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Participants must satisfy all of the following criteria to be enrolled into the study:
Exclusion criteria
Participants who meet any of the following criteria will be disqualified from entering the study:
Primary purpose
Allocation
Interventional model
Masking
285 participants in 1 patient group
Loading...
Central trial contact
Serena Dong
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal